Technology: Investment suggests RNAi is on the up
Nature
.
2014 Jun 5;510(7503):35.
doi: 10.1038/510035b.
Author
John Maraganore
1
Affiliation
1
Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
PMID:
24899296
DOI:
10.1038/510035b
No abstract available
Publication types
Letter
Comment
MeSH terms
Biotechnology / methods*
Biotechnology / trends*
Drug Delivery Systems / methods*
Humans
RNA Interference*